These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17320916)

  • 1. Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice.
    Mineur YS; Somenzi O; Picciotto MR
    Neuropharmacology; 2007 Apr; 52(5):1256-62. PubMed ID: 17320916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytisine-based nicotinic partial agonists as novel antidepressant compounds.
    Mineur YS; Eibl C; Young G; Kochevar C; Papke RL; Gündisch D; Picciotto MR
    J Pharmacol Exp Ther; 2009 Apr; 329(1):377-86. PubMed ID: 19164465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice.
    Mineur YS; Cahuzac EL; Mose TN; Bentham MP; Plantenga ME; Thompson DC; Picciotto MR
    Neuropsychopharmacology; 2018 Sep; 43(10):2118-2125. PubMed ID: 29472646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
    Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
    Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nicotinic acetylcholine receptor as a target for antidepressant drug development.
    Philip NS; Carpenter LL; Tyrka AR; Price LH
    ScientificWorldJournal; 2012; 2012():104105. PubMed ID: 22619570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.
    Mineur YS; Einstein EB; Seymour PA; Coe JW; O'neill BT; Rollema H; Picciotto MR
    Behav Pharmacol; 2011 Aug; 22(4):291-9. PubMed ID: 21566524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L; McIntosh JM
    Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytisine - From the Past to the Future.
    Paduszyńska A; Banach M; Rysz J; Dąbrowa M; Gąsiorek P; Bielecka-Dąbrowa A
    Curr Pharm Des; 2018; 24(37):4413-4423. PubMed ID: 30885113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
    Caldarone BJ; Wang D; Paterson NE; Manzano M; Fedolak A; Cavino K; Kwan M; Hanania T; Chellappan SK; Kozikowski AP; Olivier B; Picciotto MR; Ghavami A
    Psychopharmacology (Berl); 2011 Sep; 217(2):199-210. PubMed ID: 21487659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
    Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.
    Mineur YS; Einstein EB; Bentham MP; Wigestrand MB; Blakeman S; Newbold SA; Picciotto MR
    Neuropsychopharmacology; 2015 Mar; 40(4):938-46. PubMed ID: 25288485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.
    Braida D; Ponzoni L; Martucci R; Sparatore F; Gotti C; Sala M
    Psychopharmacology (Berl); 2014 May; 231(9):1975-85. PubMed ID: 24311357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
    Stokes C; Papke RL
    Neuropharmacology; 2012 Sep; 63(4):538-46. PubMed ID: 22580377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.
    Rabenstein RL; Caldarone BJ; Picciotto MR
    Psychopharmacology (Berl); 2006 Dec; 189(3):395-401. PubMed ID: 17016705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors.
    Harpsøe K; Hald H; Timmermann DB; Jensen ML; Dyhring T; Nielsen EØ; Peters D; Balle T; Gajhede M; Kastrup JS; Ahring PK
    J Biol Chem; 2013 Jan; 288(4):2559-70. PubMed ID: 23229547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist effects of cytisine in vivo.
    Radchenko EV; Dravolina OA; Bespalov AY
    Neuropharmacology; 2015 Aug; 95():206-14. PubMed ID: 25839895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL; Trocmé-Thibierge C; Guendisch D; Al Rubaiy SA; Bloom SA
    J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.